Clinical Trial Update: Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating atorvastatin to reduce myocardial damage during angiography and exploring its mechanism related to IMR. The trial is sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction
• Stable Angina
• Unstable Angina

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Central South University | Conditions: Stable Angina, Unstable Angina | Phase 2 | Status: UNKNOWN